Pharmaceutically acceptable salts of thymodepressin and...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 5/037 (2006.01) A61K 38/05 (2006.01) C07K 1/14 (2006.01) A61P 17/06 (2006.01)

Patent

CA 2571645

The present invention relates to pharmaceutically acceptable crystalline and amorphous salts of D-isoglutamyl-D-tryptophan as well as processes for their manufacture, pharmaceutical compositions comprising them, and their uses in the preparation of pharmaceutical compositions for the treatment of various conditions and/or diseases. In particular, the present invention relates to D-isoglutamyl-D-tryptophan potassium salt (1:1), D-isoglutamyl-D-tryptophan lithium salt (1:1), D-isoglutamyl-D- tryptophan calcium salt (2:1), D-isoglutamyl-D-tryptophan magnesium salt (2:1), and D-isoglutamyl- D- tryptophan organic ammonium salts (1:1).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutically acceptable salts of thymodepressin and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutically acceptable salts of thymodepressin and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically acceptable salts of thymodepressin and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1946326

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.